NuChemie was founded by Professor Craig Ogle and Anthony Fowler in 2014 to commercialize the NuLink technology developed in Professor Ogle's lab at the University of North Carolina at Charlotte.
The PCT describing the NuLink technology was filed by the University of North Carolina at Charlotte. NuChemie acquired exclusive licensing rights to the PCT.
The NuLink technology is being featured in several publications during 2016. These publications will highlight the technology, and show its application in the manufacture of nanomaterials for directed chemotherapy.
NuChemie is committed to broadening its platform of water soluble and traceable bioconjugation reagents and the development of nanomaterials for drug delivery using the NuLink technology.
Need Custom Synthesis? FREE PROJECT QUOTES - CONTACT US
Copyrights © 2015 Nu Chemie, LLC. All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission. Nu Chemie brand products are sold exclusively through Nu Chemie, LLC.